143 related articles for article (PubMed ID: 8877234)
1. The effect of budesonide (Rhinocort) in the treatment of small and medium-sized nasal polyps.
Vendelo Johansen L; Illum P; Kristensen S; Winther L; Vang Petersen S; Synnerstad B
Clin Otolaryngol Allied Sci; 1993 Dec; 18(6):524-7. PubMed ID: 8877234
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of an aqueous and a powder formulation of nasal budesonide compared in patients with nasal polyps.
Tos M; Svendstrup F; Arndal H; Orntoft S; Jakobsen J; Borum P; Schrewelius C; Larsen PL; Clement F; Barfoed C; Rømeling F; Tvermosegaard T
Am J Rhinol; 1998; 12(3):183-9. PubMed ID: 9653476
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of topical corticosteroid powder for nasal polyps: a double-blind, placebo-controlled study of budesonide.
Lildholdt T; Rundcrantz H; Lindqvist N
Clin Otolaryngol Allied Sci; 1995 Feb; 20(1):26-30. PubMed ID: 7788929
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoid treatment for nasal polyps. The use of topical budesonide powder, intramuscular betamethasone, and surgical treatment.
Lildholdt T; Rundcrantz H; Bende M; Larsen K
Arch Otolaryngol Head Neck Surg; 1997 Jun; 123(6):595-600. PubMed ID: 9193219
[TBL] [Abstract][Full Text] [Related]
5. Budesonide aqueous nasal spray and pressurized metered dose inhaler in the treatment of adult patients with seasonal allergic rhinitis.
Day J; Alexander M; Drouin M; Frankish C; Mazza J; Moote W; Patel P; Ramsdale H; Yang W
Am J Rhinol; 1997; 11(1):77-83. PubMed ID: 9065352
[TBL] [Abstract][Full Text] [Related]
6. A double-blind comparison of intranasal budesonide with placebo for nasal polyposis.
Ruhno J; Andersson B; Denburg J; Anderson M; Hitch D; Lapp P; Vanzieleghem M; Dolovich J
J Allergy Clin Immunol; 1990 Dec; 86(6 Pt 1):946-53. PubMed ID: 2262649
[TBL] [Abstract][Full Text] [Related]
7. A randomized controlled trial showing efficacy of once daily intranasal budesonide in nasal polyposis.
Filiaci F; Passali D; Puxeddu R; Schrewelius C
Rhinology; 2000 Dec; 38(4):185-90. PubMed ID: 11190754
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of budesonide aqueous nasal spray treatment in patients with nasal polyps.
Jankowski R; Schrewelius C; Bonfils P; Saban Y; Gilain L; Prades JM; Strunski V
Arch Otolaryngol Head Neck Surg; 2001 Apr; 127(4):447-52. PubMed ID: 11296057
[TBL] [Abstract][Full Text] [Related]
9. Budesonide nasal spray as prophylactic treatment after polypectomy (a double blind clinical trial).
Hartwig S; Lindén M; Laurent C; Vargö AK; Lindqvist N
J Laryngol Otol; 1988 Feb; 102(2):148-51. PubMed ID: 3279143
[TBL] [Abstract][Full Text] [Related]
10. Sensitivity of a new grading system for studying nasal polyps with the potential to detect early changes in polyp size after treatment with a topical corticosteroid (budesonide).
Johansson L; Holmberg K; Melén I; Stierna P; Bende M
Acta Otolaryngol; 2002 Jan; 122(1):49-53. PubMed ID: 11876598
[TBL] [Abstract][Full Text] [Related]
11. Comparison of budesonide Turbuhaler with budesonide aqua in the treatment of seasonal allergic rhinitis. Rhinocort Study Group.
Yang WH; Dolovich J; Drouin MA; Keith P; Haddon J; Jennings B
Can Respir J; 1998; 5(6):455-60. PubMed ID: 10070173
[TBL] [Abstract][Full Text] [Related]
12. Rebound airway obstruction and responsiveness after cessation of terbutaline: effects of budesonide.
de Jong JW; van der Mark TW; Koëter GH; Postma DS
Am J Respir Crit Care Med; 1996 Jan; 153(1):70-5. PubMed ID: 8542165
[TBL] [Abstract][Full Text] [Related]
13. Budesonide in the treatment of nasal polyposis.
Holopainen E; Grahne B; Malmberg H; Mäkinien J; Lindqvist N
Eur J Respir Dis Suppl; 1982; 122():221-8. PubMed ID: 6958488
[TBL] [Abstract][Full Text] [Related]
14. [Budesonide].
Mokr K
Dtsch Med Wochenschr; 1995 Jan; 120(4):111-2. PubMed ID: 7835236
[No Abstract] [Full Text] [Related]
15. Topical budesonide treatment reduces endothelial expression of intercellular adhesion molecules (vascular cell adhesion molecule-1 and P-selectin) and eosinophil infiltration in nasal polyps.
Tingsgaard PK; Bock T; Larsen PL; Tos M
Acta Otolaryngol; 1999; 119(3):362-8. PubMed ID: 10380744
[TBL] [Abstract][Full Text] [Related]
16. The treatment of perennial rhinitis with a new, non-halogenated, topical, aerosol packed, steroid, Budesonide.
Balle VH; Pedersen U; Engby B
Acta Otolaryngol; 1982; 94(1-2):169-73. PubMed ID: 7124383
[TBL] [Abstract][Full Text] [Related]
17. A single blind clinical comparison between 2 preparations of budesonide in the treatment of seasonal allergic rhinitis.
Irander K; Geterud A; Lindqvist N; Pipkorn U
Clin Otolaryngol Allied Sci; 1984 Aug; 9(4):235-41. PubMed ID: 6388916
[TBL] [Abstract][Full Text] [Related]
18. Powder administration of pure budesonide for the treatment of seasonal allergic rhinitis.
Pedersen B; Bundgaard Larsen B; Dahl R; Lindqvist N; Mygind N
Allergy; 1991 Nov; 46(8):582-7. PubMed ID: 1789399
[TBL] [Abstract][Full Text] [Related]
19. Expression of intercellular adhesion molecule-1 on the vascular endothelium in nasal polyps before, during and after topical glucocorticoid treatment.
Tingsgaard PK; Larsen PL; Bock T; Lange Vejlsgaard G; Tos M
Acta Otolaryngol; 1998 Jun; 118(3):404-8. PubMed ID: 9655217
[TBL] [Abstract][Full Text] [Related]
20. Dose-related efficacy and tolerability of fluticasone propionate nasal drops 400 microg once daily and twice daily in the treatment of bilateral nasal polyposis: a placebo-controlled randomized study in adult patients.
Penttilä M; Poulsen P; Hollingworth K; Holmström M
Clin Exp Allergy; 2000 Jan; 30(1):94-102. PubMed ID: 10606936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
